Orally Disintegrating Tablet Excipient Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Orally Disintegrating Tablet Excipient Market contains market size and forecasts of Orally Disintegrating Tablet Excipient in global, including the following market information:

• Global Orally Disintegrating Tablet Excipient Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Orally Disintegrating Tablet Excipient Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Orally Disintegrating Tablet Excipient companies in 2021 (%)

The global Orally Disintegrating Tablet Excipient market was valued at 17130 million in 2021 and is projected to reach US$ 21580 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Binders Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Orally Disintegrating Tablet Excipient include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland and Meggle Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orally Disintegrating Tablet Excipient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Orally Disintegrating Tablet Excipient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Orally Disintegrating Tablet Excipient Market Segment Percentages, by Type, 2021 (%)

• Binders
• Glidents
• Diluents
• Disintegrants
• Others

Global Orally Disintegrating Tablet Excipient Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Orally Disintegrating Tablet Excipient Market Segment Percentages, by Application, 2021 (%)

• Anti-Psychotics Drug
• Anti-Epileptics Drug
• Others

Global Orally Disintegrating Tablet Excipient Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Orally Disintegrating Tablet Excipient Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Orally Disintegrating Tablet Excipient revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Orally Disintegrating Tablet Excipient revenues share in global market, 2021 (%)
• Key companies Orally Disintegrating Tablet Excipient sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Orally Disintegrating Tablet Excipient sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BASF
• JRS Pharma
• Roquette
• ABF Ingredients
• DFE Pharma
• Evonik
• Merck KGaA
• Ashland
• Meggle Pharma
• Shin-Etsu
• Fuji Chemical Industries
• McePharma (Vivesa holding)
• Cargill Incorporated
• Daicel Corporation
• Anhui Sunhere Pharmaceutical